Philippe Chanson
#136,401
Most Influential Person Now
Researcher ORCID ID = 0000-0001-5096-5722
Philippe Chanson's AcademicInfluence.com Rankings
Philippe Chansonmathematics Degrees
Mathematics
#6488
World Rank
#8970
Historical Rank
Measure Theory
#1382
World Rank
#1734
Historical Rank
Download Badge
Physics Mathematics
Philippe Chanson's Degrees
- PhD Physics Université Paris Cité
- Masters Applied Mathematics University of Geneva
- Bachelors Mathematics University of Geneva
Similar Degrees You Can Earn
Why Is Philippe Chanson Influential?
(Suggest an Edit or Addition)Philippe Chanson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A consensus on criteria for cure of acromegaly. (2010) (712)
- Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper. (2016) (710)
- Guidelines for acromegaly management: an update. (2009) (704)
- A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. (1997) (451)
- Expert consensus document: A consensus on the medical treatment of acromegaly (2014) (372)
- Guidelines for acromegaly management. (2002) (338)
- Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials. (2004) (334)
- A Consensus Statement on acromegaly therapeutic outcomes (2018) (325)
- The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics. (2011) (298)
- A consensus on the diagnosis and treatment of acromegaly complications (2012) (289)
- Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. (2010) (285)
- MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma (2012) (284)
- Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. (2014) (259)
- Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation. (2009) (254)
- The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. (2003) (252)
- Consensus statement: medical management of acromegaly. (2005) (227)
- Ketoconazole in Cushing's disease: is it worth a try? (2014) (224)
- From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. (2017) (223)
- TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans. (2010) (222)
- Endocrine aspects of obstructive sleep apnea. (2010) (220)
- Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. (2005) (215)
- Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. (1998) (214)
- A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly. (2005) (212)
- Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience. (2010) (208)
- Place of cabergoline in acromegaly: a meta-analysis. (2011) (206)
- Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. (2009) (199)
- Octreotide Therapy for Thyroid-Stimulating Hormone-Secreting Pituitary Adenomas: A Follow-up of 52 Patients (1993) (199)
- Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement (2017) (179)
- Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome. (2011) (178)
- Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia. (1997) (178)
- New insights in prolactin: pathological implications (2015) (171)
- Cardiac Effects of Growth Hormone in Adults With Growth Hormone Deficiency: A Meta-Analysis (2003) (166)
- Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs. (2005) (161)
- Pituitary Apoplexy. (2015) (160)
- Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications. (2014) (157)
- Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients. (2010) (155)
- Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. (2009) (151)
- Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry. (2011) (149)
- Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. (1992) (148)
- Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients. (2012) (143)
- Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients. (2012) (142)
- Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome. (2016) (142)
- Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance. (2011) (140)
- Pituitary tumours: acromegaly. (2009) (140)
- Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. (1997) (138)
- Consensus on diagnosis and management of Cushing's disease: a guideline update. (2021) (138)
- Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study (2006) (137)
- Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database (2017) (136)
- Non-functioning pituitary adenomas. (2005) (135)
- Merits and pitfalls of mifepristone in Cushing's syndrome. (2009) (134)
- Management of clinically non-functioning pituitary adenoma. (2015) (134)
- Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism. (2005) (133)
- Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients. (2015) (133)
- The cyclic adenosine 3',5'-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas. (1995) (132)
- Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis. (2007) (130)
- Acromegaly and McCune-Albright syndrome. (2014) (127)
- Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome. (1999) (126)
- Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas. (2007) (125)
- The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients. (1995) (121)
- Diagnosis and treatment of acromegaly complications (2003) (117)
- A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds. (2006) (116)
- GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. (2012) (115)
- Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence. (2015) (114)
- Metabolic Syndrome in Cushing’s Syndrome (2010) (113)
- Multidisciplinary management of acromegaly: A consensus (2020) (112)
- Acromegaly (2019) (112)
- Slow release lanreotide treatment in acromegalic patients previously normalized by octreotide. (1994) (109)
- High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference (2017) (109)
- Kallmann's syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations. (2008) (108)
- Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients (2014) (107)
- Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry. (2017) (107)
- Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism. (2009) (104)
- Comparison of octreotide acetate LAR and lanreotide SR in patients with acromegaly (2000) (103)
- The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age (2017) (103)
- Non-syndromic congenital hypogonadotropic hypogonadism: clinical presentation and genotype-phenotype relationships. (2010) (102)
- Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas. (2001) (101)
- Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. (2010) (101)
- Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement. (2011) (101)
- Antimüllerian hormone in patients with hypogonadotropic hypogonadism. (1999) (99)
- Pregnancy outcomes following cabergoline treatment: extended results from a 12‐year observational study (2008) (99)
- Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations (2016) (98)
- Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. (2013) (97)
- Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas. (2017) (97)
- Functional hypothalamic amenorrhoea: a partial and reversible gonadotrophin deficiency of nutritional origin (1999) (97)
- Normal pituitary hypertrophy as a frequent cause of pituitary incidentaloma: a follow-up study. (2001) (96)
- Reference Values for IGF-I Serum Concentrations: Comparison of Six Immunoassays (2016) (93)
- Current management practices for acromegaly: an international survey (2011) (93)
- Normosmic Congenital Hypogonadotropic Hypogonadism Due to TAC3/TACR3 Mutations: Characterization of Neuroendocrine Phenotypes and Novel Mutations (2011) (93)
- Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide. (2000) (92)
- Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults (2008) (92)
- Diagnosis and treatment of pituitary adenomas. (2004) (92)
- Long-term outcome of patients with acromegaly and congestive heart failure. (2004) (90)
- Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas. (2004) (89)
- Clinical Pharmacokinetics of Octreotide (1993) (87)
- Type A insulin resistance syndrome revealing a novel lamin A mutation. (2005) (82)
- Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study. (2013) (81)
- Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly. (2008) (80)
- French Endocrine Society Guidance on endocrine side effects of immunotherapy (2018) (80)
- Vascular reactivity in acromegalic patients: preliminary evidence for regional endothelial dysfunction and increased sympathetic vasoconstriction (2000) (80)
- Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole. (2015) (79)
- Genetic mutations in sporadic pituitary adenomas—what to screen for? (2015) (78)
- Growth hormone as a risk for premature mortality in healthy subjects: data from the Paris prospective study (1998) (77)
- Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis. (2010) (76)
- Female gonadal function before and after treatment of acromegaly. (2010) (75)
- Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences. (2015) (73)
- McCune-Albright syndrome and acromegaly: clinical studies and responses to treatment in five cases. (1994) (73)
- Pitfall of petrosal sinus sampling in a Cushing's syndrome secondary to ectopic adrenocorticotropin-corticotropin releasing hormone (ACTH-CRH) secretion. (1998) (72)
- Hepatobiliary and Pancreatic neoplasms in patients with McCune-Albright syndrome. (2014) (70)
- Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions. (2000) (70)
- The epidemiology, diagnosis and treatment of Prolactinomas:The old and the new. (2019) (69)
- Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases. (2012) (69)
- MAFA missense mutation causes familial insulinomatosis and diabetes mellitus (2018) (69)
- Cardiac effects of growth hormone treatment in chronic heart failure: A meta-analysis. (2007) (69)
- Clinical Characteristics and Therapeutic Responses in Patients with GermLine AIP Mutations and Pituitary Adenomas : An International Collaborative Study (2010) (69)
- Comparison of fast Fourier transform and autoregressive spectral analysis for the study of heart rate variability in diabetic patients. (2005) (68)
- Control of IGF-I levels with titrated dosing of lanreotide Autogel over 48 weeks in patients with acromegaly (2008) (68)
- Osteoblastic cells derived fronm isolated lesions of fibrous dysplasia contain activating somatic mutatuions of thje Gsα gene (1995) (65)
- Cabergoline for Cushing's disease: a large retrospective multicenter study. (2017) (65)
- Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients. (2015) (64)
- Evidence of an endogenous digitalis-like factor in the plasma of patients with acromegaly. (1987) (64)
- Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: a surveillance database analysis. (2011) (61)
- The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women. (1999) (60)
- No evidence of a detrimental effect of cabergoline therapy on cardiac valves in patients with acromegaly. (2012) (60)
- Prevalence and determinants of vitamin D deficiency in healthy French adults: the VARIETE study (2016) (59)
- Cardiac Structure and Function in Cushing's Syndrome: A Cardiac Magnetic Resonance Imaging Study (2014) (59)
- Biochemical characterization of a Ca2+/NAD(P)H-dependent H2O2 generator in human thyroid tissue. (1999) (58)
- High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-up. (2012) (57)
- Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency. (2009) (57)
- Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma. (2010) (57)
- [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. (2009) (57)
- Effect of the new dopaminergic agonist CV 205–502 on plasma prolactin levels and tumour size in bromocriptine‐resistant prolactinomas (1991) (56)
- Parental origin of Gsalpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors. (2004) (56)
- Pituitary apoplexy caused by GnRH-agonist treatment revealing gonadotroph adenoma. (1995) (56)
- RAPID IMPROVEMENT IN SLEEP APNOEA OF ACROMEGALY AFTER SHORT-TERM TREATMENT WITH SOMATOSTATIN ANALOGUE SMS 201-995 (1986) (55)
- Endocrine effects of the tyrosine kinase inhibitor vandetanib in patients treated for thyroid cancer. (2011) (55)
- Post-surgical management of non-functioning pituitary adenoma. (2015) (55)
- McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patients. (2006) (54)
- McCune-Albright syndrome in adulthood. (2007) (54)
- Integrated Genomic Profiling Identifies Loss of Chromosome 11p Impacting Transcriptomic Activity in Aggressive Pituitary PRL Tumors (2011) (53)
- Management of hyperglycaemia in Cushing's disease: experts' proposals on the use of pasireotide. (2012) (52)
- A new FSHbeta mutation in a 29-year-old woman with primary amenorrhea and isolated FSH deficiency: functional characterization and ovarian response to human recombinant FSH. (2010) (51)
- Body fluid expansion in acromegaly is related to enhanced epithelial sodium channel (ENaC) activity. (2011) (50)
- Decreased regional blood flow in patients with acromegaly (1998) (49)
- Association of Anti–Porphyromonas gingivalis Antibody Titers With Nonsmoking Status in Early Rheumatoid Arthritis: Results From the Prospective French Cohort of Patients With Early Rheumatoid Arthritis (2015) (49)
- SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice—development and results from a pilot study (2015) (48)
- Macimorelin as a Diagnostic Test for Adult GH Deficiency (2018) (47)
- Prevalence of KISS1 Receptor mutations in a series of 603 patients with normosmic congenital hypogonadotrophic hypogonadism and characterization of novel mutations: a single-centre study. (2016) (46)
- Acromegaly (2008) (46)
- Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort (2016) (46)
- National acromegaly registries. (2019) (46)
- Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas. (1993) (45)
- Uncommon early-onset neuropathy in diabetic patients (1998) (45)
- Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN. (2017) (45)
- Therapeutic Management of Advanced Adrenocortical Carcinoma: What Do We Know in 2011? (2011) (45)
- Treating major depressive episodes with antidepressants can induce or worsen metabolic syndrome: results of the METADAP cohort (2015) (45)
- Management of patients and subjects at risk for multiple endocrine neoplasia type 1: MEN 1. GENEM 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1. (1997) (44)
- Lipoprotein(a) in Diabetic Patients with and Without Chronic Renal Failure (1992) (42)
- Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study (2015) (42)
- Primary hyperparathyroidism in pregnancy (2013) (42)
- Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients. (2014) (41)
- Comparison of HbA1 and Fructosamine in Diagnosis of Glucose-Tolerance Abnormalities (1990) (41)
- Management of nonfunctioning pituitary incidentaloma. (2015) (41)
- Long-term results of the surgical management of insulinoma patients with MEN1: a Groupe d'étude des Tumeurs Endocrines (GTE) retrospective study. (2015) (40)
- Impact of successful treatment of acromegaly on overnight heart rate variability and sleep apnea. (2014) (40)
- GH deficiency in adults: an epidemiological approach. (1999) (39)
- Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study (2018) (39)
- Growth Hormone Research Society perspective on biomarkers of GH action in children and adults (2018) (39)
- Anti-Müllerian Hormone and Ovarian Morphology in Women With Isolated Hypogonadotropic Hypogonadism/Kallmann Syndrome: Effects of Recombinant Human FSH (2017) (39)
- Evaluation of a New Fully Automated Assay for Plasma Intact FGF23 (2017) (39)
- Rapidly reversible myocardial edema in patients with acromegaly: assessment with ultrafast T2 mapping in a single-breath-hold MRI sequence. (2008) (38)
- Cardiovascular Disease in Type 2 Diabetes: A Review of Sex‐Related Differences in Predisposition and Prevention (2019) (38)
- Pathophysiology of renal calcium handling in acromegaly: what lies behind hypercalciuria? (2012) (38)
- Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres. (2009) (38)
- Non-responsiveness of serum gonadotropins and testosterone to pulsatile GnRH in hemochromatosis suggesting a pituitary defect. (1993) (38)
- Worse Health‐Related Quality of Life at long‐term follow‐up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYN (2018) (37)
- Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas. (2016) (36)
- Lessons from McCune-Albright syndrome-associated intraductal papillary mucinous neoplasms: : GNAS-activating mutations in pancreatic carcinogenesis. (2014) (36)
- Severe hyponatremia as a frequent revealing sign of hypopituitarism after 60 years of age. (2003) (36)
- Efficacy and Tolerability of the Long-Acting Somatostatin Analog Lanreotide in Acromegaly. A 12-Month Multicenter Study of 58 Acromegalic Patients (2000) (34)
- Cardiovascular findings and management in Turner syndrome: insights from a French cohort. (2012) (34)
- High mortality within 90 days of diagnosis in patients with Cushing's syndrome - Results from the ERCUSYN registry. (2019) (34)
- Estradiol levels in men with congenital hypogonadotropic hypogonadism and the effects of different modalities of hormonal treatment. (2011) (34)
- Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case–control study (2019) (33)
- Cabergoline in acromegaly (2017) (33)
- Efficacy and tolerability of the long-acting somatostatin analog lanreotide in acromegaly. A 12-month multicenter study of 58 acromegalic patients. French Multicenter Study Group on Lanreotide in Acromegaly. (2000) (33)
- Paradoxical response of thyrotropin to L-dopa and presence of dopaminergic receptors in a thyrotropin-secreting pituitary adenoma. (1984) (32)
- Genomic Alterations and Complex Subclonal Architecture in Sporadic GH-Secreting Pituitary Adenomas (2018) (32)
- Clinical aspects of multiple endocrine neoplasia type 1 (2021) (32)
- Non-invasive diagnostic strategy in ACTH-dependent Cushing's syndrome. (2020) (32)
- Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1 (2018) (32)
- Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome. (2017) (32)
- The prevalence of colonic polyps in acromegaly : a prospective colonoscopic and pathological study in 103 patients. (1995) (32)
- Serum calcitriol concentrations measured with a new direct automated assay in a large population of adult healthy subjects and in various clinical situations. (2015) (31)
- Computed tomography of the anterior skull base in Kallmann syndrome reveals specific ethmoid bone abnormalities associated with olfactory bulb defects. (2013) (31)
- The antigonadotropic activity of progestins (19-nortestosterone and 19-norprogesterone derivatives) is not mediated through the androgen receptor. (1996) (30)
- Drug treatment of hyperprolactinemia. (2007) (30)
- Ultralow doses of yasopressin in the management of diabetes insipidus (1987) (30)
- SFE/SFEDP adrenal insufficiency French consensus: Introduction and handbook. (2018) (30)
- Free luteinizing-hormone beta-subunit in normal subjects and patients with pituitary adenomas. (1997) (30)
- D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly. (2009) (30)
- Role of the IL‐12/IL‐35 balance in patients with Sjögren syndrome (2017) (30)
- Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the Gs alpha gene. (1995) (29)
- Hypothalamic-Pituitary-Ovarian Axis Reactivation by Kisspeptin-10 in Hyperprolactinemic Women With Chronic Amenorrhea (2017) (29)
- Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics. (2010) (29)
- Chapter 14 - Acromegaly (2014) (29)
- Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN. (2018) (29)
- Multiple endocrine neoplasia type 1 in France: clinical and genetic studies (1995) (28)
- AIP mutation in pituitary adenomas. (2011) (27)
- French consensus on the management of acromegaly. (2009) (27)
- Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study. (2015) (27)
- Management of pituitary apoplexy (2004) (27)
- How can we minimise the use of regular oral corticosteroids in asthma? (2020) (26)
- Shrinkage of a primary thyrotropin-secreting pituitary adenoma treated with the long-acting somatostatin analogue octreotide (SMS 201-995). (1991) (26)
- Medical Treatment of Acromegaly with Dopamine Agonists or Somatostatin Analogs (2015) (25)
- 68Ga-exendin-4 PET/CT detects insulinomas in patients with endogenous hyperinsulinemic hypoglycemia in MEN-1. (2019) (25)
- A Somewhat Bizarre Case of Graves Disease Due to Vitamin Treatment (2017) (25)
- Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort (2015) (25)
- A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly (2018) (25)
- Dynamic tests for the diagnosis and assessment of treatment efficacy in acromegaly (2008) (24)
- Hypogonadotropic hypogonadism as a model of post-natal testicular anti-Müllerian hormone secretion in humans (2003) (24)
- Growth hormone effects on cortical bone dimensions in young adults with childhood-onset growth hormone deficiency (2011) (24)
- The 2016-2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study. (2020) (24)
- Inhibin and follicle‐stimulating hormone levels in gonadotroph adenomas: evidence of a positive correlation with tumour volume in men (1993) (24)
- Chromogranin A as serum marker of pituitary adenomas (2003) (24)
- Growth Hormone Response to Oral Glucose Load: From Normal to Pathological Conditions (2019) (23)
- Classification of Patients With GH Disorders May Vary According to the IGF-I Assay (2017) (23)
- Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients. (2016) (23)
- Anti‐Porphyromonas gingivalis antibodies titres are associated with non‐smoking status in early rheumatoid arthritis: Results from the ESPOIR cohort (2015) (23)
- Pituitary apoplexy. (2015) (23)
- Emerging drugs for acromegaly (2008) (22)
- Cabergoline Tapering Is Almost Always Successful in Patients With Macroprolactinomas (2017) (22)
- A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues. (2017) (22)
- Absence of activating mutations in the GnRH receptor gene in human pituitary gonadotroph adenomas. (1998) (22)
- Novel PET tracers: added value for endocrine disorders (2019) (22)
- Pegvisomant treatment in patients with acromegaly in clinical practice: The French ACROSTUDY. (2015) (21)
- Sex-Related Differences in Lactotroph Tumor Aggressiveness Are Associated With a Specific Gene-Expression Signature and Genome Instability (2018) (21)
- Effectiveness of first-line pegvisomant monotherapy in acromegaly: an ACROSTUDY analysis. (2017) (21)
- Changes in metabolic parameters and cardiovascular risk factors after therapeutic control of acromegaly vary with the treatment modality. Data from the Bicêtre cohort, and review of the literature (2018) (20)
- Group 2: Adrenal insufficiency: screening methods and confirmation of diagnosis. (2017) (20)
- CONSENSUS Guidelines for Acromegaly Management (2002) (20)
- Histologically Proven Bronchial Neuroendocrine Tumors in MEN1: A GTE 51-Case Cohort Study (2017) (20)
- Growth hormone should be used only for approved indications. (2014) (19)
- Absence of receptors for thyrotropin (TSH)-releasing hormone in human TSH-secreting pituitary adenomas associated with hyperthyroidism. (1988) (19)
- Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT® validation study (2019) (19)
- ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy. (2021) (19)
- [Management of asymptomatic primary hyperparathyroidism: French Society of Endocrinology expert consensus]. (2006) (18)
- Diabetes insipidus and pregnancy. (2016) (18)
- Experience of a six-month treatment with sandostatin at increasing doses in acromegaly. (1989) (18)
- Treatment of neurogenic diabetes insipidus. (2011) (18)
- Comparative validation of the growth hormone-releasing hormone and arginine test for the diagnosis of adult growth hormone deficiency using a growth hormone assay conforming to recent international recommendations. (2010) (18)
- AIP mutations impair AhR signaling in pituitary adenoma patients fibroblasts and in GH3 cells. (2016) (18)
- Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions. (2018) (18)
- [Endoscope-assisted microsurgery for invasive endo- and suprasellar pituitary macroadenomas: a consecutive retrospective study with 13 patients]. (2005) (18)
- Expert opinion on pituitary complications in immunotherapy. (2018) (17)
- Germline Prolactin Receptor Mutation Is Not a Major Cause of Sporadic Prolactinoma in Humans (2015) (17)
- Time course of GH and IGF-1 levels following withdrawal of long-acting octreotide in acromegaly. (2000) (17)
- Variable growth hormone profiles following withdrawal of long-term 30mg slow-release lanreotide treatment in acromegalic patients: clinical implications. (2000) (17)
- HEART FAILURE RESPONDING TO OCTREOTIDE IN PATIENT WITH ACROMEGALY (1989) (17)
- Atrial natriuretic factor in patients with acromegaly (2006) (17)
- Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog. (1992) (17)
- Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time? (2021) (17)
- Hyperparathyroidism in Patients With X‐Linked Hypophosphatemia (2020) (16)
- Mutational status of EGFR, BRAF, PI3KCA and JAK2 genes in endocrine tumors (2009) (16)
- Ovarian macrocysts and gonadotrope-ovarian axis disruption in premenopausal women receiving mitotane for adrenocortical carcinoma or Cushing's disease. (2014) (16)
- Time Course of GH and IGF-1 Levels Following Withdrawal of Long-Acting Octreotide in Acromegalic Patients (2000) (15)
- Remission of Polycythemia Vera after Surgical Cure of Acromegaly (1996) (15)
- Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea. (1995) (15)
- Group 5: Acute adrenal insufficiency in adults and pediatric patients. (2017) (15)
- Benign cortisol‐secreting adrenocortical adenomas produce small amounts of androgens (2007) (15)
- [Gonadotroph pituitary adenomas]. (2000) (15)
- Multivariable prediction model for biochemical response to first-generation somatostatin receptor ligands in acromegaly. (2020) (15)
- Pitfalls for detecting interleukin-33 by ELISA in the serum of patients with primary Sjögren syndrome: comparison of different kits (2015) (15)
- Thyrotropin-releasing hormone (TRH) binding sites and thyrotropin response to TRH are regulated by thyroid hormones in human thyrotropic adenomas. (1994) (15)
- Use of radiotherapy after pituitary surgery for non-functioning pituitary adenomas. (2019) (14)
- Pituitary granuloma and pyoderma gangrenosum (1990) (14)
- An update on clinical care for pregnant women with acromegaly (2019) (14)
- Blood microbiota and metabolomic signature of major depression before and after antidepressant treatment: a prospective case–control study (2021) (13)
- Hypermethylator Phenotype and Ectopic GIP Receptor in GNAS Mutation-Negative Somatotropinomas. (2018) (13)
- Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study. (2021) (13)
- Mild pituitary phenotype in 3- and 12-month-old Aip-deficient male mice. (2016) (13)
- Genetic testing in inherited endocrine disorders: joint position paper of the European reference network on rare endocrine conditions (Endo-ERN) (2020) (12)
- Hyperfunctioning unilateral adrenal macronodule in three patients with Cushing's disease: hormonal and imaging characterization. (1993) (12)
- Nitric Oxide Synthase activity in major depressive episodes before and after antidepressant treatment: Results of a large case-control treatment study (2020) (12)
- In-frame seven amino-acid duplication in AIP arose over the last 3000 years, disrupts protein interaction and stability and is associated with gigantism (2017) (12)
- GnRH stimulation testing and serum inhibin B in males: insufficient specificity for discriminating between congenital hypogonadotropic hypogonadism from constitutional delay of growth and puberty. (2020) (11)
- FUNCTIONAL HYPOTHALAMIC AMENORRHOEA : A PARTIAL AND REVERSIBLE GONADOTROPIN DEFICIENCY OF NUTRITIONAL ORIGIN (1999) (11)
- Effects of cortisol on the heart: characterization of myocardial involvement in cushing's disease by longitudinal cardiac MRI T1 mapping (2017) (11)
- Remission of Proteinuria Following Correction of Hyperlipidemia in NIDDM Patients With Nondiabetic Glomerulopathy (1994) (11)
- Increase In Il-31 Serum Levels Is Associated With Reduced Structural Damage In Early Axial Spondyloarthritis (2018) (11)
- Primary amenorrhea revealing an occult progesterone-secreting ovarian tumor. (2008) (11)
- Diabetes increases severe COVID-19 outcomes primarily in younger adults Age and diabetes in COVID-19 severity (2021) (11)
- French law: what about a reasoned reimbursement of serum vitamin D assays? (2016) (11)
- Ten years’ clinical experience with biosimilar human growth hormone: a review of efficacy data (2017) (10)
- Less is more risky? Growth hormone and insulin-like growth factor 1 levels and cardiovascular risk (2006) (10)
- Predicting the effects of long-term medical treatment in acromegaly. At what cost? For what benefits? (1997) (10)
- Covid-19, the thyroid and the pituitary — The real state of play (2022) (10)
- Congenital hypogonadotropic hypogonadism/Kallmann Syndrome is associated with statural gain in both men and women: a monocentric study. (2019) (9)
- Central diabetes insipidus and pituitary stalk thickening in adults: distinction of neoplastic from non-neoplastic lesions. (2020) (9)
- International Multicenter Validation Study of the SAGIT ® Instrument in Acromegaly. (2021) (9)
- Ovarian dysfunction by activating mutation of GS alpha: McCune-Albright syndrome as a model. (2010) (9)
- Growth hormone excess and sternohyoid muscle mechanics in rats (2009) (8)
- [Hereditary multiple endocrine neoplasia. New genetic data and clinical applications in type 1 multiple endocrine neoplasia]. (1995) (8)
- Néoplasie endocrinienne multiple de type 1 (2000) (8)
- Primary hyperparathyroidism in pregnancy. (2016) (8)
- 68Ga-DOTATOC PET/CT in detecting neuroendocrine tumours responsible for initial or recurrent paraneoplastic Cushing’s syndrome (2019) (8)
- Does attainment of target levels of growth hormone and insulin-like growth factor I improve acromegaly prognosis? (2009) (8)
- Screening of acromegaly in adults with obstructive sleep apnea: is it worthwhile? (2018) (8)
- Treatment of TSH-secreting pituitary adenomas with octreotide : A floow-up of 52 patients (1993) (8)
- Persistent cortisol response to desmopressin predicts recurrence of Cushing's Disease in patients with post-operative corticotropic insufficiency. (2020) (8)
- Hepato-pancreato-biliary lesions are present in both Carney complex and McCune Albright syndrome Comments on P. Salpea and C. Stratakis (2014) (8)
- Early weight gain predicts later metabolic syndrome in depressed patients treated with antidepressants: Findings from the METADAP cohort. (2018) (8)
- Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndrome. (2022) (7)
- Author Correction: Acromegaly (2019) (7)
- TORSADE DE POINTES AND Q-T PROLONGATION IN SECONDARY HYPOTHYROIDISM (1988) (7)
- Sensitivity and specificity of the macimorelin test for diagnosis of AGHD. (2020) (7)
- Contribution of functionally assessed GHRHR mutations to idiopathic isolated growth hormone deficiency in patients without GH1 mutations (2019) (7)
- Somatostatin analogs in the treatment of acromegaly: the choice is now possible. (2000) (6)
- Efficacy and safety of dopamine agonists in patients treated with antipsychotics and presenting a macroprolactinoma. (2020) (6)
- Calcitonin genes (I and II) expression in human nervous and medullary thyroid carcinoma tissues (1994) (6)
- Goals of treatment (2013) (6)
- The heart in growth hormone (GH) deficiency and the cardiovascular effects of GH. (2020) (6)
- Chapter 16 – Prolactinoma (2017) (6)
- Heart failure and octreotide in acromegaly (1992) (6)
- [HAS report on vitamin D measurement: don't go from an extreme situation to another as extreme situation]. (2014) (6)
- Medical Management of Acromegaly (2006) (6)
- after neurosurgery: a study of 142 patients (2010) (6)
- Prolactin Assays and Regulation of Secretion: Animal and Human Data (2019) (6)
- [Treatment of pituitary adenoma]. (1998) (6)
- Catecholamine production in patients with gastroenteropancreatic neuroendocrine tumors. (1999) (6)
- [Update on endocrine hypertension]. (2012) (6)
- Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study (2020) (6)
- Outcome of pituitary hormone deficits after surgical treatment of nonfunctioning pituitary macroadenomas (2021) (5)
- Patrick Maison and Philippe Chanson Meta-Analysis Cardiac Effects of Growth Hormone in Adults With Growth Hormone Deficiency (2003) (5)
- [Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: appropriate indications for a reasoned reimbursment of serum vitamin D measurement]. (2014) (5)
- Treatment of acromegaly has substantial effects on body composition. A long-term follow-up study. (2021) (5)
- Reference values for insulin-like growth factor I (IGF- I) serum concentrations: comparison of six immunoassays (2016) (5)
- Early weight gain predicts later weight gain in depressed patients treated with antidepressants: Findings from the METADAP cohort. (2018) (5)
- Diabetes Increases Severe COVID-19 Outcomes Primarily in Younger Adults. (2021) (5)
- [Therapeutic strategies in somatotroph adenomas with extrasellar extension: role of the medical approach, a consensus study of the French Acromegaly Registry]. (2003) (5)
- Other Pituitary Conditions and Pregnancy. (2019) (5)
- Conservative Management of Pituitary Apoplexy (2014) (5)
- SAT-LB60 Discordant Biological Parameters of Remission in Acromegaly Do Not Increase the Risk of Hypertension or Diabetes: A Study With the Liege Acromegaly Survey Database (2020) (5)
- Fractionated stereotactic radiotherapy: an interesting alternative to stereotactic radiosurgery in acromegaly (2015) (4)
- Impact of Growth Hormone-Lowering Treatments on Heart Function in Acromegaly (2001) (4)
- Measurement of Plasma Free Luteinizing Hormoneβ -Subunit in Women (2000) (4)
- Endocrine Aspects of Successful Aging: Genes, Hormones and Lifestyles (2004) (4)
- Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 1: Diagnostic and Clinical Issues (2020) (4)
- [Medical treatment of pituitary adenoma]. (1996) (4)
- [Classification and pathophysiology of pituitary adenomas]. (2009) (4)
- [Biotherapy of neuroendocrine tumors]. (2002) (4)
- [Treatment of acromegaly with a new slow release somatostatin analog, lanreotide]. (1994) (4)
- Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas (2021) (4)
- Effects of Long-Term Administration of Sandostatin® (SMS 201–995) at Increasing Doses in 40 Acromegalic Patients. Results from the French Sandostatin Acromegaly Study Group (1988) (4)
- Pegvisomant and not somatostatin receptor ligands (SRLs) is first line medical therapy for acromegaly. (2020) (4)
- Treating hypoparathyroidism with recombinant human parathyroid hormone (1–34): long-term safety concerns (2020) (4)
- [Endocrine tumors of the pancreas (EPTs) in multiple endocrine neoplasia (MEN1): up-date on prognostic factors, diagnostic procedures and treatment]. (2007) (4)
- Management of early postoperative diabetes insipidus with parenteral desmopressin. (1988) (4)
- [Historical perspective of hormone replacement therapy]. (2005) (4)
- [Craniopharyngiomas: progress in pathogenesis and therapeutics]. (2014) (4)
- Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe (2022) (4)
- Transsphenoidal resection for pituitary adenoma in elderly versus younger patients: a systematic review and meta-analysis (2020) (3)
- Polymorphism or mutation? - The role of the R304Q missense AIP mutation in the predisposition to pituitary adenoma (2016) (3)
- Somatostatin receptor ligands induce TSH deficiency in thyrotropin-secreting pituitary adenoma. (2020) (3)
- Hyperparathyroidism in patients with X-linked hypophosphatemia (2019) (3)
- LACK OF DELAYED NEUROCOGNITIVE SIDE-EFFECTS OF GAMMA KNIFE RADIOSURGERY IN ACROMEGALY: THE LATER-AC STUDY. (2021) (3)
- Epicardial and pericardial adiposity without myocardial steatosis in Cushing's syndrome. (2021) (3)
- Prolactinomas resistant to standard doses of cabergoline: A multicenter study of 92 patients (European Journal of Endocrinology 167, 5 (651-662)) (2012) (3)
- Lower plasma vascular endothelial growth factor A in major depressive disorder not normalized after antidepressant treatment: A case control study (2019) (3)
- Measurement of plasma free luteinizing hormone beta-subunit in women. (2000) (3)
- Sagit©: A Novel Clinician-Reported Outcome for Managing Acromegaly in Clinical Practice. (2014) (3)
- Prolactin immunoassay: does the high-dose hook effect still exist? (2022) (3)
- PRE-TERM BIRTH IN WOMEN EXPOSED TO CUSHING'S DISEASE: THE BABY-CUSH STUDY. (2021) (3)
- Turner syndrome: French National Diagnosis and Care Protocol (NDCP; National Diagnosis and Care Protocol) (2022) (3)
- Pegvisomant treatment in acromegaly in clinical practice: final results of the French ACROSTUDY (312 patients). (2021) (3)
- A phase 2 study of antisense oligonucleotide therapy directed at the GH receptor demonstrates lowering of serum IGF1 in patients with acromegaly. (2015) (3)
- [Intra-sellar non-adenomatous expansive process]. (1997) (3)
- Role of the IL-12 / IL-35 balance in Sjögren ’ s syndrome 1 2 (2017) (3)
- Founder Effect in Recurring AIP Mutation Causing Familial Isolated Pituitary Adenoma Syndrome (2014) (3)
- Management of endocrine disease: Etiology and outcome of acromegaly in patients with a paradoxical GH response to glucose. (2021) (3)
- Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 2: Therapeutic Issues (2020) (3)
- Correction to: Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study (2018) (3)
- [Aggressive and resistant-to-treatment pituitary tumors]. (2013) (3)
- Cost-Utility of Acromegaly Pharmacological Treatments in a French Context (2021) (2)
- Genetic predisposition to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH): next generation sequencing ARMC5, NR3C1 (glucocorticoid receptor) and PDE11A4 (phosphodiesterase 11) in 389 patients (2019) (2)
- Predictive factors of somatostatin receptor ligand response in acromegaly - a prospective study. (2022) (2)
- Characterization of a monoclonal antibody reacting with the free human luteinizing hormone β-subunit (1996) (2)
- [Thyrotropic pituitary adenoma. Clinical aspects, course and treatment]. (1987) (2)
- Pituitary adenoma in patients with multiple endocrine neoplasia type 1 - a cohort study. (2021) (2)
- Physiopathology, Diagnosis, and Treatment of Nonfunctioning Pituitary Adenomas (2018) (2)
- Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study. (2022) (2)
- An International, Collaborative Study of the Disease Characteristics and Response to Therapy in 60 Pituitary Adenoma Patients with Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations (2008) (2)
- Reference values for IGF-I serum concentration in an adult population: use of the VARIETE cohort for two new immunoassays (2021) (2)
- CLINICALLY NON-FUNCTIONING PITUITARY ADENOMAS. (2021) (2)
- Créolité and Theology: A Theology of Créolité in the French West Indies (2005) (2)
- Clinical characteristics and outcome of acromegaly induced by ectopic secretion of GHRH: a French nationwide series of 21 cases (2012) (2)
- [Hypopituitarism following traumatic brain injury: diagnostic and therapeutic issues]. (2015) (2)
- [Discordance between the short and standard metyrapone tests in isolated corticotropin insufficiency]. (1987) (2)
- Cortisol and aldosterone responses to hypoglycemia and Na depletion in women with non-classic 21-hydroxylase deficiency. (2019) (2)
- [New insights in growth hormone physiology and pathophysiology]. (2010) (2)
- [Treatment of acromegaly: a critical analysis of the last ten years]. (2012) (2)
- Pituitary Stalk Enlargement in Adults (2020) (2)
- THU0225 Role of the IL-12/IL-35 balance in SJÖGREN'S syndrome (2017) (2)
- Diagnosis of acromegaly: black, white… and sometimes gray! (2016) (2)
- Plasma acetyl-l-carnitine and l-carnitine in major depressive episodes: a case–control study before and after treatment (2021) (2)
- [Adapting the dose to the residual concentration of infliximab in cryptogenic inflammatory diseases of the intestines]. (2015) (2)
- Glucagon-like-1 Receptor imaging specifically localizes insulinomas in patients with Multiple Endocrine Neoplasia Type 1 (MEN-1) (2016) (1)
- Cardiovascular complications of acromegaly. (2020) (1)
- [Combination of granulocyte colony-stimulating factor and erythropoietin in decompensated cirrhosis: a positive essay?]. (2015) (1)
- [Bone and metabolism]. (2018) (1)
- Improved Acromegaly Patient Satisfaction With Oral Octreotide Capsules Compared With Injectable Somatostatin Receptor Ligands in the MPOWERED Trial (2021) (1)
- Pituitary Tumours. Preface. (2009) (1)
- Pituitary MRI Features in Acromegaly due to Ectopic GHRH Secretion from a Neuroendocrine Tumor: Analysis of 30 cases. (2022) (1)
- Serum GH concentration must now be expressed in mass units in France like in the rest of the world. (2018) (1)
- Gigantism, acromegaly, and GPR101 mutations. (2015) (1)
- Efficacy and safety of osilodrostat in paraneoplastic Cushing's syndrome: a real-world multicenter study in France. (2022) (1)
- Efficacy and safety of dopamine agonists in psychiatric patients treated with antipsychotics and presenting a macroprolactinoma (2019) (1)
- Acknowledgement of reviewers 2011 (2012) (1)
- [Pituitary disease: which treatment in the future?]. (2011) (1)
- [Initial treatment of type 2 diabetes: metformin also for the Chinese!]. (2014) (1)
- Contribution of Functionally Assessed GHRHR Mutations to Idiopathic Isolated Growth Hormone Deficiency in a Cohort of 312 Unrelated Patients (2018) (1)
- [Educational meetings "crisis intervention". "Catastrophe ... that concerns me"]. (1990) (1)
- IGF-I variability over repeated measures in patients with acromegaly under long-acting somatostatin receptor ligands. (2022) (1)
- P.2.h.019 The nitric oxide synthase activity as a biomarker of major depressive episode and response to antidepressant treatment (2017) (1)
- T1 mapping in Cushing's disease: a follow-up study (2015) (1)
- Nontraumatic rhabdomyolysis during diabetic ketoacidosis (2004) (1)
- OR01-3 Pathophysiology of renal calcium handling in acromegaly: What lies behind hypercalciuria? (2012) (1)
- Apoplexy of microprolactinomas during pregnancy. (2021) (1)
- [Hypoglycemia could increase the risk of arrhythmia in diabetics, explaining the increased cardiovascular mortality in the intensive control of blood glucose]. (2014) (1)
- Adrenal tumours and hormone excess. Editorial. (2009) (1)
- Combined anticortisolic therapy by metyrapone, ketoconazole and mitotane: an alternative to adrenalectomy in severe Cushing's syndrome (2010) (1)
- [rhGH replacement therapy in adults]. (2007) (1)
- [Management of acromegaly in 2003]. (2003) (1)
- Diagnostic and therapeutic outcome in ERCUSYN: Preliminary report in over 1000 patients (2014) (1)
- Outcome of 59 pregnancies in 43 acromegalic women (2006) (1)
- [Hypothyroidism in adults]. (2006) (1)
- Evaluation of a New Fully Automated Assay for Plasma Intact FGF23 (2017) (1)
- Diabetes mellitus and muscle weakness are independently associated with mortality in patients with Cushing's syndrome. Data from ERCUSYN (2018) (1)
- Surgical debulking of GH secreting pituitary adenomas improves GH control of acromegaly by somatostatin analogs (2004) (0)
- [Not Available]. (2014) (0)
- Disease characteristics of patients with X-linked acrogigantism (X-LAG) syndrome (2015) (0)
- FROM THE CREOLE GOD TO THE GOD OF JESUS - AN ESSAY ON THE CONCEPT OF GOD IN FRENCH GUIANA (1993) (0)
- McCune-Albright Syndrome in Clinical Practice (2021) (0)
- Increased intracellular and extracellular myocardial mass on cardiac magnetic resonance imaging in patients with acromegaly (2023) (0)
- Skeletal consequences of long-term replacement therapy with human recombinant PTH(1-34) in chronic hypoparathyroidism (2022) (0)
- Title Page / Table of Contents / Preface (2010) (0)
- A MAFA missense mutation causes familial insulinomatosis and diabetes mellitus 1 2 (2018) (0)
- Cardiovascular disease during adultGH-deficiency and effects of substitutive therapy with GH (1995) (0)
- Impairment in insulin secretion without changes in insulin resistance explains hyperglycemia in patients with acromegaly treated with pasireotide LAR (2022) (0)
- Evidence of persistent mild hypercortisolism in patients medically treated for Cushing's disease: the Haircush study. (2023) (0)
- Cortisol and Aldosterone Responses to Insulin-Induced Hypoglycemia and Sodium Depletion in Women with Non-Classic 21-Hydroxylase Deficiency (2019) (0)
- Similarities and differences between thyroid and parathyroid nodules on ultrasound: the PARATH-US study (2023) (0)
- [Hospital pay for performance: a major failure]. (2014) (0)
- Regards sur l’interculturalité (2016) (0)
- MEGHA: Observational Study on Prescription of the GH Saizen in Adults in France (2015) (0)
- [Loss of hbs antigen after treatment with analogues: infrequent but stable and beneficial]. (2013) (0)
- POLYCYTHEMIA VERA IN ACROMEGALY. AUTHORS'REPLY (1997) (0)
- Gilbert ( DHEA ) in Humans Panhypopituitarism as a Model to Study the Metabolism of Dehydroepiandrosterone (1997) (0)
- The clinical and genetic characteristics of patients with gigantism (2012) (0)
- Contents Vol. 103, 2016 (2016) (0)
- Response to Letter to the Editor from Soghomonian: “Epicardial and Pericardial Adiposity Without Myocardial Steatosis in Cushing Syndrome” (2021) (0)
- Impaired insulin secretion without changes in insulin sensitivity explains hyperglycemia in patients with acromegaly treated by pasireotide LAR (2022) (0)
- New occurrence of diabetes mellitus in patients with adult onset GH deficiency (GHD) on GH therapy is dependent on the presence of metabolic syndrome at baseline: data from the Hypopituitary Control and Complication Study (HypoCCS) (2008) (0)
- Evaluation of pituitary toxicity after radiotherapy for cerebral chondrosarcomas in adult patients (2017) (0)
- NEW DIRECTIONS IN THE TREATMENT OF HYPOPARATHYROIDISM. (2023) (0)
- Serum PTH reference values established with an automated 3rd-generation assay in vitamin D-replete subjects with normal renal function. Consequence for the diagnosis of primary hyperparathyroidism and the classification of dialysis patients (2018) (0)
- Hypopituitarism in pituitary gigantism (results of an international study) (2013) (0)
- Erythropoiesis in acromegaly : effect of GH or IGF-1 ? Data from the LAS (Liege Acromegaly Survey) (2012) (0)
- Age, GH and tumor size : the triangular relation in acromegaly. Data from the LAS (Liege Acromegaly Survey) (2012) (0)
- Growth Hormone: not too much… not too less..! (2018) (0)
- Comprehensive study about the characteristics of 80 dopaminergic agonist resistants prolactinomas (2010) (0)
- [Treatment of post-neurosurgical diabetes insipidus with desmopressin by intramuscular route]. (1988) (0)
- FATHER YVES BERTRAIS, AN ESSENTIAL FIGURE IN THE HISTORY OF HMONG CHRISTIANITY (1993) (0)
- Plasma cortisol and aldosterone responses to insulin tolerance test and sodium depletion in women with non classic 21-hydroxylase deficiency caused by bi-allelic CYP21A2 mutations (NC-CAH) (2017) (0)
- Prospective evaluation of endocrine complications in adults with X-linked hypophosphatemic rickets (2014) (0)
- Recent insights in pituitary diseases. (2021) (0)
- OR7-8: A phase II randomised, open-label, parallelgroup study of the safety, tolerability, pharmacokinetics and efficacy of two subcutaneous dosing regimens of ATL1103 in adult patients with acromegaly (2014) (0)
- [The more cups of coffee, caffeinated or decaffeinated, the greater risk of type 2 diabetes]. (2014) (0)
- Effects of pregnancy on GH/IGF-1 concentrations in acromegalic women (2008) (0)
- Comprar Hormonal Control of Cell Cycle | Melmed, Shlomo | 9783540738541 | Springer (2008) (0)
- Travelling in time and space in the heart of Paris. (2020) (0)
- OR11-05 Clinical Characteristics and Reproductive Hormone Levels in 201 Men With Congenital and 479 Men With Acquired Hypogonadotropic Hypogonadism: A Single-Center Comparative Study (2020) (0)
- [Physiology of the thyroid hormones]. (1986) (0)
- Treatments of psychiatric disorders, hyperprolactinemia and dopamine agonists. (2022) (0)
- X-Linked acro-gigantism (X-LAG) due to microduplications of chromosome Xq26 : A new disorder and implications for acromegaly (2015) (0)
- Nothing is Stronger than the Good Lord (2009) (0)
- PDE11A4 (Phosphodiesterase 11 A4) is a modulator of the primary bilateral macronodular adrenal hyperplasia (PBMAH) phenotype: genotype/phenotype analysis of a cohort of 354 patients analysed by next-generation sequencing (NGS) (2021) (0)
- Acknowledgement to the Reviewers (2015) (0)
- ACRO-POLIS study: differences of symptoms and comorbidities in 472 acromegalic patients according the sex of patients and sources of clinical data (2016) (0)
- Cholecalciferol (vitamin D3) must not be considered as an endocrine disruptor (2022) (0)
- Pathophysiology of renal calcium handling in acromegaly revisited (2012) (0)
- Polycythemia Vera in Acromegaly (1997) (0)
- Increase In Il-31 Serum Levels Is Associated With Reduced Structural Damage In Early Axial Spondyloarthritis (2018) (0)
- [Prediction of risk of myocardial infarction: the metabolic syndrome no better than BMI]. (2014) (0)
- Prospective Evaluation of Bone Mineralization, PTH Regulation, and Metabolic Profile in Adult Patients with Hereditary Hypophosphatemic Rickets (2014) (0)
- Therapeutic decisions in acromegaly according to disease control in patients with acromegaly with or without prior treatment: data from baseline analysis of the SAGIT® validation study (2019) (0)
- Update in pituitary disorders. (2019) (0)
- Communications orales - Hypophyse (2008) (0)
- Correlations of the High Resolution MRI aspect of GH-secreting pituitary adenomas prior to treatment (2014) (0)
- [Beware of statins toxicity reinforced by certain macrolides]. (2013) (0)
- [The adventures of Tintin at the doctor]. (2015) (0)
- Growth Hormone and Insulin-Like Growth Factor-I Stimulate Hormonal Function and Proliferation of (1992) (0)
- Primary Amenorrhea Due to Constant High Progesterone Level Revealing a Leydig Cell Ovarian Tumor (2005) (0)
- OR32-4 Diagnostic Performance of Macimorelin vs the Insulin Tolerance Test (ITT) in 140 Patients at Varying Growth Hormone (GH) Cutpoints: A Post Hoc Analysis (2019) (0)
- Response Letter to the Editor from Woolcott & Castilla-Bancayán:Diabetes Increases Severe COVID-19 Outcomes Primarily in Younger Adults (2021) (0)
- Clinical characterization of cabergoline resistant prolactinomas : a multicenter experience on 92 patients (2012) (0)
- [Vitamin D supplementation: for and against in the BMJ!]. (2014) (0)
- Subject Index Vol. 92, 2010 (2010) (0)
- Author response for "Hyperparathyroidism in patients with X-linked hypophosphatemia" (2020) (0)
- Clinical practice outcomes from 107 patients with Cushing's syndrome treated with osilodrostat in France (2022) (0)
- CT Scan of the anterior skull base in Kallmann syndrome reveals specific ethmoid abnormalities (2012) (0)
- Current clinical practice of prenatal dexamethasone treatment in at risk pregnancies for classic 21‑hydroxylase deficiency in Europe (2021) (0)
- Second brain tumours after pituitary irradiation: lower risk than once thought. (2022) (0)
- Impact of Cinacalcet treatment on health related quality of life (HRQOL) in patients with primary hyperparathyroidism (PHPT) who have failed or in whom parathyroidectomy (PTX) is contraindicated (2008) (0)
- Acknowledgement to Reviewers (2009) (0)
- 68Ga-exendin-4 PET/CT detects insulinomas in patients with hypoglycemia in multiple endocrine neoplasia type 1 (2019) (0)
- GH or IGF-1 : which one is raising blood glucose ? Hints from the LAS (Liege Acromegaly Survey) (2012) (0)
- Characterization of a monoclonal antibody reacting with the free human luteinizing hormone beta-subunit. (1996) (0)
- Human Cancer Biology MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma (2012) (0)
- Increased prevalence of colonic adenomas in acromegalics patiens (1994) (0)
- MON-288 TSH Deficiency in Patients on Somatostatin Analog for TSH-PitNET (2020) (0)
- Dlagnosis of secondary hypoadrenalism (1996) (0)
- CLINICAL AND HISTOLOGICAL FOLLOW-UP AFTER LIVER TRANSPLANTATION (LT) FOR HEREDITARY HEMOCHROMATOSIS (HH). (2003) (0)
- [Screening of multiple endocrine neoplasias type 1. Reflexions of the Study Group on Multiple Endocrine Neoplasias type 1]. (1995) (0)
- Role of 68Ga-DOTATOC PET/CT in Insulinoma According to 3 Different Contexts: A Retrospective Study (2022) (0)
- Correction to: Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study (2020) (0)
- A missense mutation in the islet-enriched transcription factor MAFA leads to familial insulinomatosis and diabetes (2016) (0)
- Antithyroid arthritis syndrome (2016) (0)
- The malignant potential of oncocytic adrenal tumours should not be underestimated (2019) (0)
- Serum GH concentrations must now be expressed in mass units in France…as in the rest of the world. (2017) (0)
- Benefit to risk ratio of mitotane high starting dose strategy in 22 patients with adrenocortical carcinoma (ACC): a prospective evaluation (2010) (0)
- Pegvisomant is More Effective in Stunting Growth than Somatostatin Analogs in Childhood Acromegaly/Gigantism (2016) (0)
- AB0150 Understanding The Role of The IL12/iL35 Balance in Sjögren Syndrome (2016) (0)
- 8th Annual European Meeting on the Management of Acromegaly Milan, Italy (2019) (0)
- SAT-428 Effect of Age, Body Mass Index, and Sex on the Performance of Macimorelin for the Diagnosis of Adult Growth Hormone Deficiency: A Post Hoc Analysis (2019) (0)
- Thytropin producing pituitary adenomas : a large belgo-french experience of 41 cases (2001) (0)
- Du son à la scription, la trace indélébile du nom (2012) (0)
- Mutations and Pituitary Adenomas: An International Collaborative Study AIP Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line (2010) (0)
- Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the Cranioexe randomized placebo-controlled trial (2023) (0)
- Title: Peripheral tryptophan, serotonin, kynurenine and their metabolites in major depression: a case-control study Running Head: Tryptophan pathway in major depression (2019) (0)
- Subject Index Vol. 47, 1997 (1997) (0)
- Autoévaluations de l'article : Néoplasie endocrinienne multiple de type 1 (2009) (0)
- Carpal tunnel syndrome in acromegaly is also related to median nerve oedema (2020) (0)
- Assessment of disease control in patients with acromegaly treated with long-acting somatostatin analogs (SMSa) varies according to the time when IGF-I levels are measured during the month following the injection (2020) (0)
- [Steroid-secreting gonad tumors]. (2005) (0)
- Preliminary Testing of the Sagit Tool: A Tool to Help Endocrinologists in Their Management of Patients with Acromegaly in Clinical Practice (2013) (0)
- Acknowledgement to the Reviewers (2019) (0)
- Drug treatment of hyperprolactinemia Traitement médical de l ’ hyperprolactinemie (2007) (0)
- Antisense oligomer therapy directed at the GH receptor is associated with reduction in circulating GHBP levels (2015) (0)
- RF13 | PMON146 Molecular determinants of cavernous sinus invasion by pituitary adenomas: functional in vitro studies and in vivo investigations in a rat model of invasive pituitary tumorigenesis obtained by stereotactic pituitary GC cells injection (2022) (0)
- Growth hormone secretion during pregnancy in an acromegalic woman (1996) (0)
- Pituitary stalk thickening: neoplastic or not? - author's response to the letter by Wang et al. (2020) (0)
- Reproductive phenotypes in men with acquired or congenital hypogonadotropic hypogonadism: a comparative study. (2022) (0)
- Reproductive phenotype in 265 men with congenital hypogonadotropic hypogonadism and 531 men with acquired hypogonadotropic hypogonadism: a monocentric comparative study (2019) (0)
- Identification of clinical parameters predictive of ARMC5 mutation in a large cohort of primary bilateral macronodular adrenal hyperplasia (PBMAH) patients. (2020) (0)
- Aging of the newly diagnosed acromegalic patients : data frome the LAS (Liege Acromegaly Survey) (2012) (0)
- [Pituitary adenoma]. (2002) (0)
- Iconographies supplémentaires de l'article : Néoplasie endocrinienne multiple de type 1 (2009) (0)
- Lysine demethylase KDM1A and ectopic expression of GIP-receptor in somatotropinomas of patients with paradoxical response to oral glucose (2023) (0)
- [Not Available]. (2013) (0)
- European observational study of ketoconazole for endogenous cushing's syndrome in collaboration with European registry on cushing's syndrome ERCUSYN: PASS ketoconazole study design and rationale (2019) (0)
- OR16-1 Best of The Journal of Clinical Endocrinology & Metabolism: Macimorelin as a Diagnostic Test for Adult GH Deficiency (2019) (0)
- What patients with acromegaly have to say about their diagnostic pathway: A qualitative study (2019) (0)
- Isolated progesterone secretion by an ovarian Leydig cell tumour: I, hormonal and immunohistochemical characterization II, effects on the gonadotrope axis (2006) (0)
- Rapid assessment of surgical success in patients with acromegaly: GH, IGF-I, or both? (2017) (0)
- INSL3 in 268 male patients with congenital hypogonadotropic hypogonadism (CHH): effects of different modalities of hormonal treatment (2013) (0)
- [In choosing an antihypertensive, the body mass index is not too important]. (2015) (0)
- OR11,63 Growth hormone treatment has a positive effect on spine bone mineral density in young adults with childhood-onset growth hormone deficiency: a meta-analysis (2010) (0)
- [Pathology of the pituitary stalk and diabetes insipidis]. (2005) (0)
- PTH in situ measurement in patients with hyperparathyroidism: single-centre experience of 179 patients. (2022) (0)
- Liège Acromegaly Survey (LAS): First snapshot (2010) (0)
- Loss of lysine demethylase KDM1A in GIP-dependent bilateral macronodular adrenal hyperplasia with Cushing's syndrome (2022) (0)
- HTA et hypokaliémie… attention aux images… ! (2000) (0)
- TREATMENTS ON HEART FUNCTION IN ACROMEGALY (2001) (0)
- Corticotroph tumor progression after bilateral adrenalectomy: data from ERCUSYN. (2022) (0)
- [Pentoxifylline against prednisolone in severe acute alcoholic hepatitis: a Korean trial]. (2014) (0)
- MON-244 GnRH Test Does Not Efficiently Discriminate Congenital Isolated Hypogonadotropic Hypogonadism from Constitutional Delay of Growth and Puberty in Males (2019) (0)
- Life expectancy and likelihood of surgery in multiple endocrine neoplasia type 1: AFCE and GTE cohort study. (2022) (0)
- Persistence of mild hypercortisolism in patients with Cushing's disease treated with cortisol-lowering drugs : the Haircush study (2023) (0)
- 2018 Consensus of the French Society of Endocrinology: endocrine toxicities of cancer immunotherapies (2019) (0)
- Cushing's Disease is associated with reversible cardiac dysfunction and remodelling assessed by CMR (2014) (0)
- Consensus Management of nonfunctioning pituitary incidentaloma Prise en charge des incidentalomes hypophysaires non fonctionnels (2015) (0)
- Diagnosis of secondary hypoadrenalism. (1996) (0)
- P-23 Bone mineral density and alkaline phosphatase in growth hormone-treated GH-deficient young adults (2008) (0)
- Targeting invasive pituitary adenomas: in vitro studies and in vivo investigations in a murine model of invasive pituitary tumors obtained by orthotopic pituitary GC cells injection (2022) (0)
- Faculty Opinions recommendation of Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy. (2009) (0)
- Medical treatment of macroprolactinomas Escalation and de-escalation of dopamine agonist dose (2016) (0)
- Outcome of Pituitary Hormone Deficits After Surgical Treatment of Non-functioning Pituitary Macroadenomas (NFPMA) (2021) (0)
- [Thyrotropic deficiency]. (1998) (0)
- mitotane measurement during the first three months of follow-up (2011) (0)
- Characteristics of patients with pituitary gigantism: results of an international study (2013) (0)
- [The effect of nicotine on adipose tissue through AMPK α2]. (2015) (0)
- ' s response to reviews Title : Predictive factors of adrenal insufficiency in patients admitted to acute medical wards : a case control study (2012) (0)
- Symptoms and comorbidities at diagnosis of 472 acromegalic patients diagnosed between 2009 and 2014 (2015) (0)
- OR3,17 Acromegaly is associated with enhanced renal and extrarenal epithelial sodium channel (ENaC) activity in humans (2010) (0)
- [Drugs that make gain weight or make lose weight]. (2015) (0)
- Pituitary Tumours (2000) (0)
- The genetic causes of pituitary gigantism (2015) (0)
- [Lower threshold of TSH for treatment of hypothyroidism: a benefit/risk balance remains uncertain]. (2014) (0)
- SUN-444 Efficacy and Safety of Dopamine Agonists in Psychiatric Patients Treated with Antipsychotics and Presenting a Macroprolactinoma (2019) (0)
- Therapy for Acromegaly (2014) (0)
- Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome (2018) (0)
- Communications affichées - Reproduction (2008) (0)
- Acknowledgment of Reviewers 2016 and 2017 (2018) (0)
- Néoplasie endocrinienne multiple de type 1 (type 1 multiple endocrine neoplasia) (1999) (0)
- [The effect of a intermittent blockade of the vagus nerve on morbid obesity is disappointing]. (2014) (0)
- [Diabetes in elderly subjects]. (1992) (0)
- Long-term prognosis of congestive heart failure in patients with acromegaly (2003) (0)
- Characterization of prolatinomas resistant to dopaminergic agonists (2008) (0)
- Acknowledgement to the Reviewers (2009) (0)
- Lessons from the Liege Acromegaly Survey (LAS) (2013) (0)
- Endocrinological diagnosis and treatment of TSH-secreting pituitary adenomas (2021) (0)
- [Obstructive sleep apnea: snoring is not very predictive if it is IMC<30]. (2013) (0)
- [A meeting specially devoted to pituitary in the absence of Rolf Gaillard. How is it possible?]. (2012) (0)
- Hypertension in Acromegaly (2020) (0)
- [Not Available]. (2014) (0)
- Contents, Vol. 47, 1997 (1997) (0)
- OR04-4 Loss of KDM1A in Bilateral Macronodular Adrenal Hyperplasia With GIP-Dependent Cushing's Syndrome and in Acromegaly With Paradoxical GH Response to Oral Glucose (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Philippe Chanson?
Philippe Chanson is affiliated with the following schools:
